Funded Grants

Back to results

Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure on brain development, cognition and activity related risk for obesity: A longitudinal study with 10 year olds

Project Overview

Dr.  Hutchison‘s training is in lifespan psychology and her research broadly focuses on children’s cognitive and social development. her current research project examines cognitive and health outcomes in children whose mothers’ were treated with antidepressant medication during pregnancy. About 10- 20% of women experience depressed mood during pregnancy and Serotonin Reuptake Inhibitors are the most prevalent medication for treating maternal mood disorders during pregnancy. This is an exciting contribution to this field of study because not much is known about the long term impact of prenatal SRI exposure on children’s cognition and health.

Principal Investigator

Sarah Hutchison , University of British Columbia

Partners and Donors

University of British Columbia

Project Complete

Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure on brain development, cognition and activity related risk for obesity: A longitudinal study with 10 year olds

  • Program Type

    Capacity building grants

  • Area of research

    Mental Health

  • Disease Area

    Mental illness

  • Competition

    Brain Canada - Kids Brain Health Network Training Awards

  • Province

    British Columbia

  • Start Date

    2016

  • Total Grant Amount

    $100,000

  • Health Canada Contribution

    $50,000